iCAD (NASDAQ:ICAD) Earns Sell Rating from Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of iCAD (NASDAQ:ICAD - Get Free Report) in a report issued on Sunday. The brokerage set a "sell" rating on the technology company's stock.

Several other research analysts have also issued reports on the company. Craig Hallum lowered iCAD from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 16th. BTIG Research cut iCAD from a "buy" rating to a "neutral" rating in a report on Wednesday, April 16th. Finally, Laidlaw reaffirmed a "hold" rating on shares of iCAD in a research note on Thursday, April 17th.

iCAD Stock Up 3.2 %

ICAD stock traded up $0.11 during midday trading on Friday, reaching $3.60. The stock had a trading volume of 546,370 shares, compared to its average volume of 386,111. The firm has a market cap of $98.81 million, a price-to-earnings ratio of -27.69 and a beta of 1.35. iCAD has a twelve month low of $1.18 and a twelve month high of $3.78. The business has a fifty day simple moving average of $2.45 and a two-hundred day simple moving average of $2.28.

iCAD (NASDAQ:ICAD - Get Free Report) last issued its quarterly earnings results on Wednesday, March 19th. The technology company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.05) by $0.02. iCAD had a negative net margin of 17.81% and a negative return on equity of 15.65%. The company had revenue of $5.41 million during the quarter, compared to analysts' expectations of $4.72 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ICAD. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of iCAD during the 1st quarter valued at about $505,000. Granahan Investment Management LLC bought a new position in iCAD in the fourth quarter valued at approximately $96,000. Integrated Wealth Concepts LLC acquired a new position in shares of iCAD in the fourth quarter valued at approximately $92,000. Wells Fargo & Company MN raised its holdings in shares of iCAD by 51.3% during the fourth quarter. Wells Fargo & Company MN now owns 39,542 shares of the technology company's stock worth $72,000 after acquiring an additional 13,402 shares during the period. Finally, Perritt Capital Management Inc lifted its position in iCAD by 1.9% in the 4th quarter. Perritt Capital Management Inc now owns 189,100 shares of the technology company's stock valued at $346,000 after acquiring an additional 3,600 shares in the last quarter. 24.61% of the stock is currently owned by institutional investors.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.